Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +2 vs. Q2 2023
- Shares held
- 7.50M
- −1.47M (−16.4%) vs. Q2 2023
- Total value
- $8.40M
- −$5.11M (−37.8%) vs. Q2 2023
- New holders
- 4
- 9 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 137 | $0 | 0.00% | −341−71.3% | Reduced |
| BNP Paribas Arbitrage, SA | 59 | $66 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $84 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $112 | 0.00% | 00.0% | Unchanged |
| Householder Group Estate & Retirement Specialist, LLC | 100 | $112 | 0.00% | +100 | New |
| Barclays PLC | 200 | $224 | 0.00% | +100+100.0% | Added |
| Allworth Financial LP | 267 | $300 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $310 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $347 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $381 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $441 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 469 | $525 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,212 | $1.36K | 0.00% | +1,058+687.0% | Added |
| Parallel Advisors, LLC | 2,376 | $2.66K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,165 | $5.79K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,668 | $7.47K | 0.00% | +5,756+631.1% | Added |
| Morgan Stanley | 9,542 | $10.7K | 0.00% | +2,293+31.6% | Added |
| Brinker Capital Investments, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,148 | $11.4K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $12.3K | 0.00% | 00.0% | Unchanged |
| Cohen Lawrence B | 11,126 | $12.5K | 0.01% | 00.0% | Unchanged |
| Strategic Blueprint, LLC | 12,200 | $13.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 19,645 | $22.0K | 0.00% | −49,884−71.7% | Reduced |
| XTX Topco Ltd | 31,940 | $35.8K | 0.01% | +31,940 | New |
| Northern Trust Corp | 43,858 | $49.1K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,527 | $60.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 56,611 | $63.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 59,928 | $67.1K | 0.00% | −1,479−2.4% | Reduced |
| Mariner, LLC | 75,079 | $84.1K | 0.00% | +75,079 | New |
| Jane Street Group, LLC | 75,885 | $85.0K | 0.00% | +75,885 | New |
| Susquehanna International Group, LLP | 103,982 | $116.5K | 0.00% | −8,790−7.8% | Reduced |
| Two Sigma Advisers, LP | 131,900 | $147.7K | 0.00% | −59,289−31.0% | Reduced |
| Bridgeway Capital Management, LLC | 138,495 | $155.1K | 0.00% | +83,495+151.8% | Added |
| Bank of America Corp | 172,962 | $193.7K | 0.00% | +10,023+6.2% | Added |
| Alphabet Inc. | 189,122 | $211.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 219,603 | $246.0K | 0.00% | +32,441+17.3% | Added |
| Renaissance Technologies LLC | 325,000 | $364.0K | 0.00% | +36,300+12.6% | Added |
| BlackRock Inc. | 336,442 | $376.8K | 0.00% | −3,273−1.0% | Reduced |
| EPIQ Capital Group, LLC | 926,500 | $1.04M | 0.56% | −6,680−0.7% | Reduced |
| Vanguard Group Inc | 949,991 | $1.06M | 0.00% | +56,700+6.3% | Added |
| Tang Capital Management LLC | 3,498,868 | $3.92M | 0.55% | −114,412−3.2% | Reduced |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −1,411,839−100.0% | Sold out |
| Knightsbridge Asset Management, LLC | 0 | $0 | 0.00% | −228,605−100.0% | Sold out |